{"version":"1.0","provider_name":"Universal Medica","provider_url":"https:\/\/www.universalmedica.com\/en\/","author_name":"universalmedica","author_url":"https:\/\/www.universalmedica.com\/en\/author\/universalmedica\/","title":"Strengths and limitations of remote pharmacovigilance audit - Universal Medica","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1NdNAYP3Qo\"><a href=\"https:\/\/www.universalmedica.com\/en\/strengths-and-limitations-of-remote-pharmacovigilance-audit\/\">Strengths and limitations of remote pharmacovigilance audit<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.universalmedica.com\/en\/strengths-and-limitations-of-remote-pharmacovigilance-audit\/embed\/#?secret=1NdNAYP3Qo\" width=\"600\" height=\"338\" title=\"&#8220;Strengths and limitations of remote pharmacovigilance audit&#8221; &#8212; Universal Medica\" data-secret=\"1NdNAYP3Qo\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.universalmedica.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/07\/Copie-de-Copie-de-Copie-de-Sans-titre-1.jpg","thumbnail_width":500,"thumbnail_height":300,"description":"The emergence of COVID-19 and the economic consequences and travel restrictions that this pandemic has caused have led pharmaceutical companies to review their audit methods. Remote pharmacovigilance auditing has been implemented exponentially, but what are its Strengths and limitations? Strengths: Maintain audit planning (internal, contractors) in any circumstances (pandemic or other crisis situations\u2026), more flexibility [&hellip;]"}